NVNO pullback after a breakoutSort of a breakout followed by a pullback, one of the best setups there is, and r/r is pretty nice too at 3. Taking it above 6.6
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−1.0666 EUR
−21.08 M EUR
0.00 EUR
19.07 M
About enVVeno Medical Corporation
Sector
Industry
CEO
Robert Andrew Berman
Website
Headquarters
Irvine
Founded
1999
ISIN
US29415J1060
FIGI
BBG00NNNW445
enVVeno Medical Corp. is a development stage medical device company, which develops tissue based solutions that are designed to be life sustaining or life enhancing for patients with cardiovascular disease, and peripheral arterial and venous disease. Its products include VenoValve and enVVe. The company was founded by Norman Jaffe on December 22, 1999 and is headquartered in Irvine, CA.
Related stocks
NVNOTook a little nibble on NVNO. Chat doesnt look to bad with price at the bottom of the range and making a nice W. The book also look pretty clean with a low share count finviz.com
NVNO: for sell in short termhi there,
we are short on NVNO for short time ... so be careful ... look the chart for more informations ...
> Good luck
See all ideas
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on SWB exchange enVVeno Medical Corporation stocks are traded under the ticker 5HJ.
We've gathered analysts' opinions on enVVeno Medical Corporation future price: according to them, 5HJ price has a max estimate of 10.76 EUR and a min estimate of 10.76 EUR. Watch 5HJ chart and read a more detailed enVVeno Medical Corporation stock forecast: see what analysts think of enVVeno Medical Corporation and suggest that you do with its stocks.
Yes, you can track enVVeno Medical Corporation financials in yearly and quarterly reports right on TradingView.
enVVeno Medical Corporation is going to release the next earnings report on Nov 6, 2025. Keep track of upcoming events with our Earnings Calendar.
5HJ earnings for the last quarter are −0.28 EUR per share, whereas the estimation was −0.24 EUR resulting in a −17.86% surprise. The estimated earnings for the next quarter are −0.26 EUR per share. See more details about enVVeno Medical Corporation earnings.
enVVeno Medical Corporation revenue for the last quarter amounts to 0.00 EUR, matching the estimated figure, and no changes in revenue are expected for the next quarter.
5HJ net income for the last quarter is −5.68 M EUR, while the quarter before that showed −4.16 M EUR of net income which accounts for −36.52% change. Track more enVVeno Medical Corporation financial stats to get the full picture.
No, 5HJ doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Sep 8, 2025, the company has 37 employees. See our rating of the largest employees — is enVVeno Medical Corporation on this list?
Like other stocks, 5HJ shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade enVVeno Medical Corporation stock right from TradingView charts — choose your broker and connect to your account.